CAR+ extracellular vesicles predict ICANS in patients with B cell lymphomas treated with CD19-directed CAR T cellsGianluca Storci, Francesca Bonifazi, Lucrezia Rossini et al.|Journal of Clinical Investigation|2024Cited by 28
Peripheral blood cellular profile at pre-lymphodepletion is associated with CD19-targeted CAR-T cell-associated neurotoxicitySerena De Matteis, Francesca Bonifazi, Michele Dicataldo et al.|Frontiers in Immunology|2023Cited by 17
Metabolic profile evolution in relapsed/refractory B-cell non-Hodgkin lymphoma patients treated with CD19 chimeric antigen receptor T-cell therapy and implications in clinical outcomeSerena De Matteis, Francesca Bonifazi, Laura Del Coco et al.|Haematologica|2024Cited by 3
Pre-treatment circulating microRNA signatures predict outcomes of anti-CD19 CAR T-cell therapyMaria Naddeo, Francesca Bonifazi, Roberta Roncarati et al.|Haematologica|2026Cited by 0